Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Joni Cobb and Pipeline took ‘a leap of faith’ that’s paying off
In 2006, Joni Cobb was busy coaxing Kansas business executives to apply for a program honing their leadership skills. Then a state-subsidized program, Pipeline would cultivate promising entrepreneurs that would tangentially grow the Sunflower State’s economy with their firms. Extolled as rigorous, the Pipeline sales pitch hit snags with its intensiveness and novelty. Skeptical entrepreneurs…
The Pipeline fellowship’s journey to the Emerald Isle in photos
In an educational adventure focused on finance and global business strategy, the Pipeline entrepreneurial fellowship program ventured across the pond for a week of relationship building. I tagged along not only to observe the experience — expect more on that front soon — but to capture some moments with my camera. This smattering of photos, which…
Kansas City startups flex pitch skills in national Kauffman contest
Four Kansas City area startups — and one Lawrence, Kan. firm — have qualified to the top 40 of Ewing Marion Kauffman Foundation’s 1 in a Million pitch competition. The competition offers those who have presented at 1 Million Cups in the last year a chance to snag a $25,000 prize. Hundreds of applicants — who…
Big Bang leverages smart city success, LaunchKC momentum
Editor’s note: This content is sponsored by LaunchKC but independently produced by Startland News. As Kansas City becomes a hotbed for smart city tech, one local startup is providing a spine for streamlined communication among the devices cities will leverage. Kansas City-based Big Bang’s Internet of Things software aims to work as the “central nervous…